Key Takeaways
- Shares of UiPath declined 7.7% Wednesday, reaching an intraday low of $11.00 from a previous closing price of $12.04.
- Trading volume was exceptionally thin, coming in 85% below typical levels.
- Analyst consensus remains at “Hold” with an average price target of $13.80 across 17 firms.
- The company reported quarterly revenue of $418.38 million, representing 17.3% year-over-year growth and exceeding forecasts.
- Convergence Investment Partners established a fresh $4.4 million stake in PATH during the first quarter.
Shares of UiPath (PATH) experienced a significant decline Wednesday, falling 7.7% and briefly touching $11.00 during intraday trading before settling at $11.11. This represented a notable pullback from the previous session’s close of $12.04.
The decline was particularly noteworthy due to exceptionally light market participation. Just 6.4 million shares traded hands throughout the session ā representing an 85% decrease from the typical average of 41.4 million shares. Such reduced liquidity often amplifies price movements beyond what might occur under normal trading conditions.
Currently, the automation software provider’s 50-day moving average stands precisely at $11.11, while its 200-day moving average rests at $11.75. The company maintains a market capitalization of roughly $5.50 billion.
Analyst Sentiment Remains Mixed
Wall Street’s outlook on PATH leans toward caution. Among 17 analysts tracking the stock, 14 maintain “Hold” ratings, two recommend “Buy,” and one suggests “Sell.” The average price target across all analysts is $13.80.
Recent analyst activity has skewed negative. BMO Capital Markets reduced its price target from $14 down to $13 while maintaining a “market perform” stance. Morgan Stanley lowered its forecast from $17 to $15 with an “equal weight” designation. UBS decreased its target from $13 to $12, maintaining a “neutral” outlook. Bank of America made a modest upward adjustment from $12 to $13 but continued its “underperform” rating.
Needham stands out as the most bullish voice, maintaining a “buy” recommendation with a $15 price objective.
Strong Quarterly Results Overshadowed by Selloff
The selloff appears disconnected from fundamentals, as PATH delivered strong financial results in late May. The company reported quarterly revenue of $418.38 million, significantly surpassing the analyst consensus of $397.54 million. This figure marked a solid 17.3% increase compared to the same period last year.
Earnings per share reached $0.15, precisely meeting analyst expectations. This compared favorably to the $0.11 EPS posted in the year-ago quarter. The company achieved a net margin of 19.58% and posted a return on equity of 7.92%.
Looking ahead, Wall Street anticipates full-year earnings of $0.40 per share.
The stock’s 52-week range spans from $9.20 to $19.84, placing Wednesday’s trading level significantly below the annual peak.
From an institutional ownership perspective, Convergence Investment Partners established a new stake during Q1, acquiring 396,363 shares valued at roughly $4.4 million, representing approximately 0.08% ownership. Overall, institutional investors control 62.50% of outstanding shares.
Additional smaller investment firms initiated positions in Q4, including HighMark Wealth Management, Raleigh Capital Management, and Atlas Capital Advisors, though each position was valued below $40,000.
PATH concluded Wednesday’s session at $11.11, hovering precisely at its 50-day moving average level.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
